Cornerstone Therapeutics Completes Acquisition of EKR Therapeutics
June 27, 2012 07:05 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Jun 27, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
Expands hospital product portfolio with cardiovascular products CARDENE® I.V....
Cornerstone Therapeutics Appoints Dr. Laura Shawver to Board of Directors
June 12, 2012 08:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Jun 12, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on commercializing products for the hospital, niche respiratory and...
Court Orders Dismissal of CUROSURF(R) Case
May 24, 2012 18:10 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - May 24, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that on May 18, 2012 the United States District Court for the Western District of New York...
Cornerstone Therapeutics Reports First Quarter 2012 Financial Results
May 15, 2012 07:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - May 15, 2012) -
Signs acquisition agreement with EKR Therapeutics, sharpening strategic focus on hospital and specialty markets
...
Cornerstone Therapeutics to Acquire EKR Therapeutics, Accelerating Expansion in Hospital Market
May 14, 2012 21:01 ET
|
Cornerstone Therapeutics
CARY, NC and BEDMINSTER, NJ--(Marketwire - May 14, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
Cornerstone expands hospital product portfolio with...
Cornerstone Therapeutics to Host First Quarter 2012 Conference Call
May 08, 2012 16:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - May 8, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Tuesday, May 15, 2012, to discuss its...
Cornerstone Therapeutics Receives FDA Acceptance for CRTX 080 NDA for Treatment of Hyponatremia
March 13, 2012 08:00 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 13, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX), a specialty pharmaceutical company focused on acquiring, developing and commercializing proprietary products for...
Cornerstone Therapeutics Reports Fiscal Year 2011 Financial Results
March 08, 2012 07:30 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 8, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX)
Strategic Products grow 7% year-over-year to $79.9 Million
Acquisition...
Cornerstone Therapeutics Divests Its Anti-Infective Assets
March 07, 2012 08:45 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 7, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced the divestiture of certain product rights to Factive® (gemifloxacin mesylate) tablets and the...
Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2011 Conference Call
March 02, 2012 16:15 ET
|
Cornerstone Therapeutics
CARY, NC--(Marketwire - Mar 2, 2012) - Cornerstone Therapeutics Inc. (NASDAQ: CRTX) today announced that it will host a conference call at 8:30 a.m. ET on Thursday, March 8, 2012, to discuss its...